TherapeuticsMD: Q1 Earnings Insights

Comments
Loading...

TherapeuticsMD TXMD reported its Q1 earnings results on Monday, May 16, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

Earnings

TherapeuticsMD missed estimated earnings by 18.0%, reporting an EPS of $-4.72 versus an estimate of $-4.0.

Revenue was down $533.00 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.01 which was followed by a 0.0% increase in the share price the next day.

Here's a look at TherapeuticsMD's past performance:

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -0.08 -0.10 -0.11 -0.12
EPS Actual -0.09 -0.11 -0.11 -0.11
Revenue Estimate 29.39M 25.87M 22.11M 19.77M
Revenue Actual 18.68M 25.41M 23.00M 19.87M

To track all earnings releases for TherapeuticsMD visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

TXMD Logo
TXMDTherapeuticsMD Inc
$0.79914.92%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum5.09
Growth25.48
Quality-
Value63.05
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In: